Loop Industries, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Loop Industries, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $10.89M | May 30, 2025 |
| FY2025 | Feb 29, 2024 | $153.0K | May 30, 2025 |
| FY2024 | Feb 28, 2023 | $173.0K | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $0 | May 18, 2023 |
| FY2022 | Feb 28, 2021 | $0 | May 27, 2022 |
| FY2021 | Feb 29, 2020 | $0 | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $0 | May 5, 2020 |
| FY2020 | Feb 28, 2018 | $0 | May 5, 2020 |
| FY2019 | Feb 28, 2017 | $0 | May 8, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($15.06M) | May 30, 2025 |
| FY2025 | Feb 29, 2024 | ($21.09M) | May 30, 2025 |
| FY2024 | Feb 28, 2023 | ($21.30M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($44.92M) | May 18, 2023 |
| FY2022 | Feb 28, 2021 | ($36.34M) | May 27, 2022 |
| FY2021 | Feb 29, 2020 | ($14.51M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($17.54M) | May 5, 2020 |
| FY2020 | Feb 28, 2018 | ($14.04M) | May 5, 2020 |
| FY2019 | Feb 28, 2017 | ($4.11M) | May 8, 2019 |
| FY2017 | Feb 29, 2016 | ($2.84M) | Jan 12, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Feb 28, 2017 | ($4.11M) | Jan 12, 2018 |
| FY2017 | Feb 29, 2016 | ($2.84M) | Jan 12, 2018 |
| FY2016 | Feb 28, 2015 | ($287.4K) | Jun 15, 2016 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $6.86M | May 30, 2025 |
| FY2025 | Feb 29, 2024 | $11.38M | May 30, 2025 |
| FY2024 | Feb 28, 2023 | $17.35M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $27.74M | May 18, 2023 |
| FY2022 | Feb 28, 2021 | $18.69M | May 27, 2022 |
| FY2021 | Feb 29, 2020 | $4.72M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $3.45M | May 5, 2020 |
| FY2020 | Feb 28, 2018 | $6.69M | May 5, 2020 |
| FY2019 | Feb 28, 2017 | $1.45M | May 8, 2019 |
| FY2017 | Feb 29, 2016 | $801.7K | Jan 12, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($2.12M) | May 30, 2025 |
| FY2025 | Feb 29, 2024 | ($18.05M) | May 30, 2025 |
| FY2024 | Feb 28, 2023 | ($34.89M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($40.56M) | May 18, 2023 |
| FY2022 | Feb 28, 2021 | ($22.49M) | May 27, 2022 |
| FY2021 | Feb 29, 2020 | ($9.09M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($7.56M) | May 5, 2020 |
| FY2020 | Feb 28, 2018 | ($6.39M) | May 5, 2020 |
| FY2019 | Feb 28, 2017 | ($2.83M) | May 8, 2019 |
| FY2017 | Feb 29, 2016 | ($1.11M) | Jan 12, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $0 | May 30, 2025 |
| FY2025 | Feb 29, 2024 | $5.16M | May 30, 2025 |
| FY2024 | Feb 28, 2023 | $81.0K | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $4.82M | May 18, 2023 |
| FY2022 | Feb 28, 2021 | $1.74M | May 27, 2022 |
| FY2021 | Feb 29, 2020 | $2.44M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $1.89M | May 5, 2020 |
| FY2020 | Feb 28, 2018 | $2.71M | May 5, 2020 |
| FY2019 | Feb 28, 2017 | $513.0K | May 8, 2019 |
| FY2017 | Feb 29, 2016 | $1.60M | Jan 12, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $18.58M | May 30, 2025 |
| FY2025 | Feb 29, 2024 | $20.55M | May 30, 2025 |
| FY2024 | Feb 28, 2023 | $40.56M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $59.22M | May 18, 2023 |
| FY2022 | Feb 28, 2021 | $43.40M | May 27, 2022 |
| FY2021 | Feb 29, 2020 | $42.84M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $12.16M | May 5, 2020 |
| FY2019 | Feb 28, 2018 | $13.40M | May 8, 2019 |
| FY2018 | Feb 28, 2017 | $2.94M | May 14, 2018 |
| FY2017 | Feb 29, 2016 | $2.48M | Jan 12, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $18.21M | May 30, 2025 |
| FY2025 | Feb 29, 2024 | $6.41M | May 30, 2025 |
| FY2024 | Feb 28, 2023 | $6.82M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $13.23M | May 18, 2023 |
| FY2022 | Feb 28, 2021 | $10.58M | May 27, 2022 |
| FY2021 | Feb 29, 2020 | $4.37M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $9.53M | May 5, 2020 |
| FY2019 | Feb 28, 2018 | $3.07M | May 8, 2019 |
| FY2018 | Feb 28, 2017 | $800.0K | May 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $367.0K | May 30, 2025 |
| FY2025 | Feb 29, 2024 | $14.14M | May 30, 2025 |
| FY2025 | Feb 28, 2023 | $33.74M | May 30, 2025 |
| FY2024 | Feb 28, 2022 | $46.00M | May 29, 2024 |
| FY2023 | Feb 28, 2021 | $32.82M | May 18, 2023 |
| FY2022 | Feb 29, 2020 | $38.46M | May 27, 2022 |
| FY2021 | Feb 28, 2019 | $2.63M | Jun 1, 2021 |
| FY2020 | Feb 28, 2018 | $10.32M | May 5, 2020 |
| FY2020 | Feb 28, 2017 | $2.14M | May 5, 2020 |
| FY2019 | Feb 29, 2016 | $1.42M | May 8, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($192.03M) | May 30, 2025 |
| FY2025 | Feb 29, 2024 | ($176.97M) | May 30, 2025 |
| FY2024 | Feb 28, 2023 | ($155.88M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($134.58M) | May 18, 2023 |
| FY2022 | Feb 28, 2021 | ($89.66M) | May 27, 2022 |
| FY2021 | Feb 29, 2020 | ($53.32M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($38.81M) | May 5, 2020 |
| FY2019 | Feb 28, 2018 | ($21.28M) | May 8, 2019 |
| FY2018 | Feb 28, 2017 | ($7.24M) | May 14, 2018 |
| FY2017 | Feb 29, 2016 | ($3.12M) | Jan 12, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $12.97M | May 30, 2025 |
| FY2024 | Sep 29, 2024 | $6.96M | May 29, 2024 |
| FY2024 | Feb 29, 2024 | $6.96M | May 29, 2024 |
| FY2024 | Feb 28, 2023 | $29.59M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $44.06M | May 18, 2023 |
| FY2022 | Feb 28, 2021 | $35.22M | May 27, 2022 |
| FY2021 | Feb 29, 2020 | $33.72M | Jun 1, 2021 |
| FY2021 | Feb 28, 2019 | $5.83M | Jun 1, 2021 |
| FY2020 | Feb 28, 2018 | $8.15M | May 5, 2020 |
| FY2020 | Feb 28, 2017 | $916.5K | May 5, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $3.22M | May 30, 2025 |
| FY2024 | Feb 29, 2024 | $3.51M | May 29, 2024 |
| FY2023 | Feb 28, 2023 | $3.56M | May 18, 2023 |
| FY2022 | Feb 28, 2022 | $3.62M | May 27, 2022 |
| FY2021 | Feb 28, 2021 | $2.68M | Jun 1, 2021 |
| FY2019 | Feb 28, 2019 | $1.01M | May 8, 2019 |
| FY2019 | Feb 28, 2018 | $1.09M | May 8, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | May 30, 2025 |
| FY2025 | Feb 29, 2024 | 0 | May 30, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 47.62M | May 30, 2025 |
| FY2025 | Feb 29, 2024 | 47.53M | May 30, 2025 |
| FY2024 | Feb 28, 2023 | 47.47M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | 47.39M | May 18, 2023 |
| FY2022 | Feb 28, 2021 | 42.41M | May 27, 2022 |
| FY2021 | Feb 29, 2020 | 39.91M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | 33.81M | May 5, 2020 |
| FY2019 | Feb 28, 2018 | 33.75M | May 8, 2019 |
| FY2018 | Feb 28, 2017 | 31.45M | May 14, 2018 |
| FY2017 | Feb 29, 2016 | 29.91M | Jan 12, 2018 |